MYH9 Fusion

CI-VAR-00001255Explore in graph →CIViC 2686

Curated evidence

Evidence by cancer (1 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

civicCuratedShowing 1–1 of 1 evidence items across 1 cancer context on this page · levels, directions and significance as curated at the source; each row links to its CIViC record.

Molecular profile	Therapy	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
Childhood B-cell Acute Lymphoblastic Leukemia1unmapped disease
IL2RB::MYH9 Fusion	(diagnostic)	Diagnostic	C	Supports Positive	2	submitted	EID7259 In a cohort of 264 patients with Ph-like B-ALL, a high risk female had a IL2RB-MYH9 rearrangement. MYH9 as a fusion partner had not been previously reported. PMID 25207766 · Roberts et al., 2014 · Open in CIViC	civic

ClinVar

Clinical significance (0)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

Data not yet available

No ClinVar interpretation attached to this variant.